Table 2.

Demographic features and treatment outcomes for patients who completed treatment.

	Escitalopram	Sertraline	Venlafaxine-XR	Total
N	136	169	148	453
Females	71	96	80	247
% Female	52.5	56.8	54.1	54.5
Average age (years)	38.27	38.72	37.98	38.34
HRSD17 baseline	21.45	21.74	21.45	21.56
HRSD17 week-8	8.62	9.25	9.01	8.98
VQIDS-SR5 baseline	8.01	8.34	7.99	8.13
VQIDS-SR5 week-8	3.26	3.35	3.21	3.28
% Remission (HRSD17)	51.5	46.7	44.6	47.5
% Response (HRSD17)	66.2	66.9	66.2	66.4